Cargando…
Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?
The lack of diversity in cancer trials is a multifaceted, decades-old problem that has remained persistent despite efforts to increase the number of participants from underrepresented racial and ethnic backgrounds. This lack of meaningful improvement is a problem that continues to perpetuate inequit...
Autor principal: | Mutale, Faith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881739/ https://www.ncbi.nlm.nih.gov/pubmed/36727023 http://dx.doi.org/10.6004/jadpro.2022.13.8.2 |
Ejemplares similares
-
Refractive surgery: Where are we today?
por: Sachdev, Mahipal S
Publicado: (2020) -
Cataract surgery – Where are we today and what do we need?
por: Heda, Aarti, et al.
Publicado: (2022) -
New drug discovery: Where are we heading to?
por: Yadav, M. R.
Publicado: (2013) -
Where do we go from here
por: Ranganathan, Kannan
Publicado: (2012) -
Imaging the pediatric retina – Where are we headed?
por: Sengupta, Sabyasachi
Publicado: (2019)